- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02595151
Real-time Observation of Microcirculatory Hemodynamics in Gastric Intestinal Metaplasia by Confocal Laser Endomicroscopy
Real-time Observation of Microcirculatory Hemodynamics in Gastric Intestinal Metaplasia by Confocal Laser Endomicroscopy: a Feasibility Study
Study Overview
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Shandong
-
Jinan, Shandong, China, 250012
- Recruiting
- Qilu Hospital, Shandong University
-
Contact:
- Xiuli Zuo, PhD
- Phone Number: 15588818685 15588818685
- Email: xiulizuo@gmail.com
-
Sub-Investigator:
- Yafei Yin, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male or Female aged 18-80 ;
- Those fulfilling the criteria of GIM according to the study by Yuting Guo et al were included.
Exclusion Criteria:
- patients younger than 18 years or older than 80 years;
- finding of acute GI bleeding, gastrectomy or known upper gastrointestinal cancer;
- unwillingness to participate in this study;
- contraindications to CLE, such as fluorescein allergy, hepatic or renal dysfunction, jaundice, pregnancy and/or breast feeding, coagulopathy.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
gastric intestinal metaplasia
Those fulfilling the criteria of GIM by CLE according to the study by Yuting Guo et al were included.
|
The CLE procedure did not differ from that of conventional colonoscopy, except for the additional storage of pCLE images and videos in the gastric antrum.
|
|
normal gastric
diagnosed during routine colonoscopy procedures.
|
The CLE procedure did not differ from that of conventional colonoscopy, except for the additional storage of pCLE images and videos in the gastric antrum.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
blood flow state
Time Frame: 5 months
|
Flow determination cannot yet be done automatically. It requires a semi-quantitative analysis involving subjective assessment. Assessment of flow determination was based on the previously published consensus criteria, in which flow was classified into seven grades. Flow was categorized as: "linear flow" (fast and continuous flow, like plastic tape without grainy), "linear particle flow"(fast and continuous flow, like ribbon with mild grainy), "particle linear flow"(fast and continuous flow, like cotton tape with obvious grainy), "particle flow"(sluggish flow like mud-sand flow), "slowly particle flow"(slow but continuous), "particle of pendulum flow"(swinging silt flow) and "stagnate"(no flow). |
5 months
|
|
microvascular area in μm2
Time Frame: 5 months
|
We analyzed the CLE images by using Adobe PhotoShop CS6 software.
Ten images selected randomly and good displays of the vascular network were chosen from each sample for the analysis of the vascular structures.
The Picture Cutout Guide and straight line tool were used to manually measure the area and length of each vascular segment.
Each vascular segment was labeled and measured.
We defined the microvascular length as the ratio of microvascular area to the microvascular diameter.
The final measurement results of the microvascular area and diameter are the average of the 10 groups' testing values, respcetively.
The results were exported in an Excel file and reported as the mean ± standard error (SD) for each individual case.
|
5 months
|
|
microvascular diameter in μm
Time Frame: 5 months
|
We analyzed the CLE images by using Adobe PhotoShop CS6 software.
Ten images selected randomly and good displays of the vascular network were chosen from each sample for the analysis of the vascular structures.
The Picture Cutout Guide and straight line tool were used to manually measure the area and length of each vascular segment.
Each vascular segment was labeled and measured.
We defined the microvascular length as the ratio of microvascular area to the microvascular diameter.
The final measurement results of the microvascular area and diameter are the average of the 10 groups' testing values, respcetively.
The results were exported in an Excel file and reported as the mean ± standard error (SD) for each individual case.
|
5 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
vascular morphology
Time Frame: 5 months
|
It included normal or tortuous and dilation.
|
5 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Xiuli Zuo, PhD, Qilu Hospital of Shandong University
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015SDU-QILU-G001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.